Key market opportunities include the rising prevalence of chronic diseases and increased regulatory approvals driving demand ...
Charles River Laboratories International, Inc. (NYSE: CRL) and Gazi University Faculty of Medicine, today announced a gene therapy contract development and manufacturing organization (CDMO) ...
The Atlanta Falcons have several critical pieces set to enter a contract year in 2026, with several in line to receive an ...
Avalanche Digest on MSN

This is even better than we expected

Click the link <a href="http://kalshi.com/r/DIGESTNHL">http://kalshi.com/r/DIGESTNHL</a> or download the Kalshi App and use ...
What started as an injury replacement after the Kings were suffering several guys out on the IR, Taylor Ward took advantage ...
Before the blockbuster trades and postseason runs, there was just one player willing to try to build something special in San ...
Charles River Laboratories International Inc. and Gazi University Faculty of Medicine have entered a gene therapy CDMO ...
Yardbarker on MSN

Jets Recall Isaak Phillips

The Jets announced they’ve recalled defenseman Isaak Phillips from AHL Manitoba. He was up with them for nine days earlier ...
Astellas Gene Therapies remains intent on treating X-linked Myotubular Myopathy (XLMTM) through a gene therapy—but instead of AAV-based resamirigene bilparvovec (AT132), Astellas is now partnering ...
Looking at pitchers such as Joe Musgrove and Tyler Glasnow provides a snapshot of what Peralta could fetch in an extension.
The market size of CGT products is expected to continue to rise by 2031 and reach $63 billion. CGTs have yielded commercial gains for several pharma companies. For example, some of the top-selling CGT ...
Both Panarin and Lafrenière could be on the move before the trade deadline, but the process of dealing each of them is ...